ConductScience.org, home
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
API referenceFor AI assistants

Trial · NCT00096278

Adverse events376

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 376

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherDehydrationMetabolism and nutrition disordersOxaliplatin + Leucovorin + 5-Fluorouracil531,326
otherDehydrationMetabolism and nutrition disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab671,334
otherDepressionPsychiatric disordersOxaliplatin + Leucovorin + 5-Fluorouracil531,326
otherDepressionPsychiatric disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab701,334
otherDiarrheaGastrointestinal disordersOxaliplatin + Leucovorin + 5-Fluorouracil1281,326
otherDiarrheaGastrointestinal disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab1531,334
otherFatigueGeneral disordersOxaliplatin + Leucovorin + 5-Fluorouracil981,326
otherFatigueGeneral disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab1221,334
otherHypertensionVascular disordersOxaliplatin + Leucovorin + 5-Fluorouracil241,326
otherHypertensionVascular disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab1721,334
otherNeutrophil count decreasedInvestigationsOxaliplatin + Leucovorin + 5-Fluorouracil4331,326
otherNeutrophil count decreasedInvestigationsOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab4001,334
otherPeripheral sensory neuropathyNervous system disordersOxaliplatin + Leucovorin + 5-Fluorouracil5861,326
otherPeripheral sensory neuropathyNervous system disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab6601,334
otherThromboembolic eventVascular disordersOxaliplatin + Leucovorin + 5-Fluorouracil641,326
otherThromboembolic eventVascular disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab851,334
otherWhite blood cell decreasedInvestigationsOxaliplatin + Leucovorin + 5-Fluorouracil731,326
otherWhite blood cell decreasedInvestigationsOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab581,334
seriousAbdominal distensionGastrointestinal disordersOxaliplatin + Leucovorin + 5-Fluorouracil01,326
seriousAbdominal distensionGastrointestinal disordersOxaliplatin + Leucovorin + 5-Fluorouracil + Bevacizumab31,334

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00096278/events

API referenceFor AI assistants